Saturday May 26, 2018
Home India Delhi governm...

Delhi government to probe dengue death row

0
//
47
Rout family. Photo Credit: http://indianexpress.com
Republish
Reprint

By NewsGram Staff-Writer

The Delhi government will soon announce a magisterial inquiry into the 7-year-old Avinash Rout’s death considering the outrage that broke out after the same, according to reports.

Rout family. Photo Credit: http://indianexpress.com
Rout family. Photo Credit: http://indianexpress.com

The boy died of dengue this week after being denied admission to five hospitals in the city. He was admitted to a hospital in Tughlakabad later where he died on the 8th of September.

After cremating Avinash’s body, his parents jumped off the terrace of a four storey building.

According to relatives and friends, the government would be looking into the CCTV footage of the hospitals wherein Avinash was rejected medical help. Avinash was refused admission on September 7 to five hospitals.

A senior official said, “On Saturday, the government took Avinash’s treatment record from Batra hospital. The 50-page record also includes a case history from his treating doctor. It stated that the family had been referred from five private hospitals and mentioned their names. This is based on what the parents told doctors while admitting their son,” as quoted in the leading daily.

He further added that show-cause notices were issued to the hospitals only after the records were thoroughly checked.

The five hospitals — Moolchand, Max Saket, Akash hospital, Irene hospital, and Saket City hospital — were issued show-cause notices on Saturday seeking the reasons as to why the registration of the aforementioned hospitals should not be cancelled said the director of health services Sunil Bhatnagar.

The notice also asked as to why the hospital refuted the Delhi government’s order on August 28 to not deny admission to any dengue patient on account of lack of beds.

According to sources after Avinash’s treatment records will be looked over by the top Delhi government officials, matters of the probe would be submitted for a magisterial inquiry.

Max and Saket City hospitals said Avinash had not been treated in their emergency wards. “The CCTV footage will be the only way to corroborate these claims. Since the parents are dead, we will have to contact friends and relatives. This might be possible only under a magisterial probe,” explained the official, as quoted in a leading daily.

Click here for reuse options!
Copyright 2015 NewsGram

Next Story

Dengue Vaccine Should Not Be Used Widely: UN Health Agency

UN Health Agency issued an important statement regarding the dengue vaccine

0
//
23
Dengue vaccine.
A Manila Health officer shows off a pair of vials of the anti-dengue vaccine Dengvaxia after being recalled from local government health centers Tuesday, Dec. 5, 2017 in Manila, Philippines. The World Health Organization says the first-ever vaccine for dengue needs to be dealt with in "a much safer way," meaning that the shot should mostly be given to people who have previously been infected with the disease. VOA

The World Health Organization says the first-ever vaccine for dengue needs to be dealt with in “a much safer way,” meaning that the shot should mostly be given to people who have previously been infected with the disease.

In November, the vaccine’s manufacturer, Sanofi Pasteur, said people who had never been sickened by dengue before were at risk of developing a more serious disease after getting the shot.

After a two-day meeting this week, WHO’s independent vaccines group said it now had proof the vaccine should only be used “exclusively or almost exclusively in people who have already been infected with dengue.”

Also Read: Anti-dengue Antibody Drug May Neutralize Zika Virus

The U.N. health agency said a test should be developed so doctors would be able to quickly tell if people had previously been sickened by dengue – but the group acknowledged doing that so isn’t straightforward.

“We see significant obstacles in using the vaccine this way, but we are confident this also spurs the development of a rapid diagnostic test,” said Dr. Joachim Hombach, executive secretary of WHO’s expert group, during a news conference Thursday.

Representational image for dengue vaccination
Representational image. Wikimedia Commons

Sanofi said last year that doctors should consider whether people might have been previously infected with dengue before deciding whether they should risk getting immunized. The company said it expected to take a 100 million euro ($118 million) loss based on that news.

People who catch dengue more than once can be at risk of a hemorrhagic version of the disease. The mosquito-spread virus is found in tropical and sub-tropical climates across Latin and South America, Asia, Africa and elsewhere. It causes a flu-like disease that can cause joint pain, nausea, vomiting and a rash. In severe cases, dengue can result in breathing problems, hemorrhaging and organ failure.

About half the world’s population is at risk of dengue; WHO estimates that about 96 million people are sickened by the viral infection every year.

Also Read: Dengue fever may increase risk of stroke: Study

Following Sanofi’s announcement last year, the Philippines halted its dengue immunization program, the world’s first national vaccination program for dengue. The government also demanded a refund of more than 3 billion pesos ($59 million) from Sanofi and is considering further legal action.

In February, the Philippines said the vaccine was potentially linked to the deaths of three people: all of them died of dengue despite having received the vaccine.

The country imposed a symbolic fine of $2,000 on Sanofi and suspended the vaccine’s approval, charging that the drugmaker broke rules on how the shot was registered and marketed.

More than 730,000 children aged 9 and above in the Philippines have received at least one dose of the dengue vaccine, usually delivered in three doses.

There is no specific treatment for dengue and there are no other licensed vaccines on the market.  VOA

Next Story